Navigation Links
Germany, Japan and Russia Will be the First Markets to Experience Peak Cases in Several Commercially Significant Drug Markets

BURLINGTON, Mass., Dec. 4, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that over the next six decades prevalent cases of several diseases that represent commercially important opportunities for drug developers will peak and then decline. The Strategic Insights report entitled Timing Matters: Shifting Opportunities for Drug Developers as Global Populations Age, finds that Germany, Japan and Russia will be the first markets to experience a peak in cases of chronic obstructive pulmonary disease, major depressive disorder, age-related macular degeneration and Alzheimer's disease.

The report examines the peak cases phenomenon in key commercial disease markets of Brazil, urban China, Germany, Japan, Russia and the United States, and explores the interaction between population size, demographics and peak cases. Because markets are at different stages of the population aging, peak cases will be reached at different times across markets and diseases.

According to the report, diseases with a higher prevalence in younger populations are more sensitive to the reductive impact of aging populations. For example, prevalent cases of major depressive disorder will decline owing to aging demographics across five of the six markets examined.

"Disease populations — and therefore opportunities for drug developers — will continue to expand for diseases with their highest prevalence in older age-groups. For example, prevalent cases in Alzheimer's disease will increase by more than 800 percent in urban China between 2012 and 2072," said Decision Resources Senior Epidemiologist Donal Minihan, Ph.D. "The United States is largely immune to the peak cases phenomenon because its immigration and reproductive rate will maintain an increasing population with a balanced spread across age-groups."

About Decision Resources
Decision Resources ( is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ResMed Receives Injunctions against APEX and BMC in Germany, Continues Enforcement of Patents in Europe
2. Medical Device Market Opportunities in Germany, 2012
3. PELOBIOTECH to Distribute ReachBios Products in Germany, Austria and Switzerland
4. TriReme Medical and Japanese Partner Century Medical, Inc., Receive Shonin Approval for GliderXtreme PTA Catheter in Japan
5. Japanese Fund Moves Quickly to Invest in Promising Technology Against Malaria, Tuberculosis And Chagas Disease
6. The Japanese Embolization Particle Market Will Witness Significant Market Activity And Rapid Growth Due To New Product Approvals
7. The Japanese Market For Peripheral Vascular Devices Will Be Characterized By New Product Launches In Many Segments
8. Japan Pharmaceutical Market Outlook
9. Japan Vietnam Medical Instrument Company Ranked as One of Top 3 Companies in Vietnam
10. Japan Vietnam Medical Instrument Company Announces $7M Capital Raise
11. Japanese Heart Valve Device Market Growth Will Spike With The Launch of Transcatheter Heart Valves
Post Your Comments:
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ( ... Cardiac Pacemaker Market Outlook to 2019 - Rise in Cardiac ... " report to their offering. ... Boston scientific and others. --> ... Medtronic, Biotronik, Boston scientific and others. ...
(Date:11/26/2015)... Research and Markets ( ) ... Future Horizons and Growth Strategies in the Japanese ... Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report ... --> This new 247-page report ... drug monitoring market, including emerging tests, technologies, instrumentation, ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director ... about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for ... and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... On November ... United States District Court of Connecticut on behalf of a home health care worker ... all current or former home health care workers employed by Humana, Inc., Humana at ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an ... is being more and more widely heralded as a breakthrough for performing hernia repairs. ... has over traditional laparoscopic surgery is that it can greatly reduce the pain that ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dental professionals who would like to become ... invited to attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will ... , As the co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio ...
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon Health Partners, the ... Wimbledon Athletics Facebook page to educate the public, parents and school ... About 2,000 people under the age of 25 die from sudden cardiac arrest ...
Breaking Medicine News(10 mins):